{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:48:09Z","timestamp":1790423289460,"version":"4.1.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T00:00:00Z","timestamp":1550448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T00:00:00Z","timestamp":1550448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007601","name":"EC | Horizon 2020","doi-asserted-by":"publisher","award":["642937"],"award-info":[{"award-number":["642937"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"EC | Horizon 2020","doi-asserted-by":"publisher","award":["642937"],"award-info":[{"award-number":["642937"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"EC | Horizon 2020","doi-asserted-by":"publisher","award":["642937"],"award-info":[{"award-number":["642937"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Renal Cysts and Diabetes Syndrome (RCAD) is an autosomal dominant disorder caused by mutations in the <jats:italic>HNF1B<\/jats:italic> gene encoding for the transcriptional factor hepatocyte nuclear factor-1B. RCAD is characterized as a multi-organ disease, with a broad spectrum of symptoms including kidney abnormalities (renal cysts, renal hypodysplasia, single kidney, horseshoe kidneys, hydronephrosis), early-onset diabetes mellitus, abnormal liver function, pancreatic hypoplasia and genital tract malformations. In the present study, using capillary electrophoresis coupled to mass spectrometry (CE-MS), we investigated the urinary proteome of a pediatric cohort of RCAD patients and different controls to identify peptide biomarkers and obtain further insights into the pathophysiology of this disorder. As a result, 146 peptides were found to be associated with RCAD in 22 pediatric patients when compared to 22 healthy age-matched controls. A classifier based on these peptides was generated and further tested on an independent cohort, clearly discriminating RCAD patients from different groups of controls. This study demonstrates that the urinary proteome of pediatric RCAD patients differs from autosomal dominant polycystic kidney disease (<jats:italic>PKD1<\/jats:italic>, <jats:italic>PKD<\/jats:italic>2), congenital nephrotic syndrome (<jats:italic>NPHS1<\/jats:italic>, <jats:italic>NPHS2<\/jats:italic>, <jats:italic>NPHS4<\/jats:italic>, <jats:italic>NPHS9<\/jats:italic>) as well as from chronic kidney disease conditions, suggesting differences between the pathophysiology behind these disorders.<\/jats:p>","DOI":"10.1038\/s41598-019-38713-5","type":"journal-article","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T11:03:22Z","timestamp":1550487802000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Urinary proteome signature of Renal Cysts and Diabetes syndrome in children"],"prefix":"10.1038","volume":"9","author":[{"given":"Pierbruno","family":"Ricci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Krochmal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Pejchinovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Daina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosa","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Goea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Belczacka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6194-3446","authenticated-orcid":false,"given":"Giuseppe","family":"Remuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Umbhauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Drube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Pape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Mischak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Decramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7471-372X","authenticated-orcid":false,"given":"Joost P.","family":"Schanstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Cereghini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3465-2173","authenticated-orcid":false,"given":"Petra","family":"Z\u00fcrbig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,18]]},"reference":[{"issue":"1","key":"38713_CR1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1086\/316945","volume":"68","author":"CBM Bingham","year":"2001","unstructured":"Bingham, C. B. M. et al. Mutations in the hepatocyte nuclear factor-1beta gene are associated with familial hypoplastic glomerulocystic kidney disease. Am J Hum Genet Jan 68(1), 219\u201324 (2001).","journal-title":"Am J Hum Genet Jan"},{"key":"38713_CR2","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/ng1297-384","volume":"17","author":"Y Horikawa","year":"1997","unstructured":"Horikawa, Y. et al. Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nature Genetics 17, 384\u2013385, https:\/\/doi.org\/10.1038\/ng1297-384 (1997).","journal-title":"Nature Genetics"},{"key":"38713_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nrneph.2014.232","volume":"11","author":"RL Clissold","year":"2015","unstructured":"Clissold, R. L., Hamilton, A. J., Hattersley, A. T., Ellard, S. & Bingham, C. HNF1B-associated renal and extra-renal disease-an expanding clinical spectrum. Nature Reviews Nephrology 11, 102\u2013112, https:\/\/doi.org\/10.1038\/nrneph.2014.232 (2015).","journal-title":"Nature Reviews Nephrology"},{"key":"38713_CR4","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1093\/hmg\/ddl161","volume":"15","author":"C Haumaitre","year":"2006","unstructured":"Haumaitre, C. et al. Severe pancreas hypoplasia and multicystic renal dysplasia in two human fetuses carrying novel HNF1 beta\/MODY5 mutations. Human Molecular Genetics 15, 2363\u20132375, https:\/\/doi.org\/10.1093\/hmg\/ddl161 (2006).","journal-title":"Human Molecular Genetics"},{"key":"38713_CR5","first-page":"34","volume":"31","author":"N Kato","year":"2009","unstructured":"Kato, N. & Motoyama, T. Expression of Hepatocyte Nucler Factor-1 beta in Human Urogenital Tract During the Embryonic Stage. Analytical and Quantitative Cytology and Histology 31, 34\u201340 (2009).","journal-title":"Analytical and Quantitative Cytology and Histology"},{"key":"38713_CR6","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/pd.4264","volume":"34","author":"D Body-Bechou","year":"2014","unstructured":"Body-Bechou, D. et al. TCF2\/HNF-1beta mutations: 3 cases of fetal severe pancreatic agenesis or hypoplasia and multicystic renal dysplasia. Prenatal Diagnosis 34, 90\u201393, https:\/\/doi.org\/10.1002\/pd.4264 (2014).","journal-title":"Prenatal Diagnosis"},{"key":"38713_CR7","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/pd.4858","volume":"36","author":"H Duval","year":"2016","unstructured":"Duval, H. et al. Fetal anomalies associated with HNF1B mutations: report of 20 autopsy cases. Prenatal Diagnosis 36, 744\u2013751, https:\/\/doi.org\/10.1002\/pd.4858 (2016).","journal-title":"Prenatal Diagnosis"},{"key":"38713_CR8","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/j.1464-5491.2008.02460.x","volume":"25","author":"IS Haldorsen","year":"2008","unstructured":"Haldorsen, I. S. et al. Lack of pancreatic body and tail in HNF1B mutation carriers. Diabetic Medicine 25, 782\u2013787, https:\/\/doi.org\/10.1111\/j.1464-5491.2008.02460.x (2008).","journal-title":"Diabetic Medicine"},{"issue":"11","key":"38713_CR9","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1093\/ndt\/gfh348","volume":"19","author":"C Bingham","year":"2004","unstructured":"Bingham, C. & Renal, H. A. cysts and diabetes syndrome resulting from mutations in hepatocyte nuclear factor-1beta. Nephrol Dial Transplant. Nov 19(11), 2703\u20138 (2004).","journal-title":"Nephrol Dial Transplant. Nov"},{"key":"38713_CR10","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/humu.10212","volume":"21","author":"PD Stenson","year":"2003","unstructured":"Stenson, P. D. et al. Human gene mutation database (HGMD (R)): 2003 update. Human Mutation 21, 577\u2013581, https:\/\/doi.org\/10.1002\/humu.10212 (2003).","journal-title":"Human Mutation"},{"key":"38713_CR11","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s00467-010-1454-9","volume":"25","author":"M Nakayama","year":"2010","unstructured":"Nakayama, M. et al. HNF1B alterations associated with congenital anomalies of the kidney and urinary tract. Pediatric Nephrology 25, 1073\u20131079, https:\/\/doi.org\/10.1007\/s00467-010-1454-9 (2010).","journal-title":"Pediatric Nephrology"},{"key":"38713_CR12","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/ki.2015.28","volume":"88","author":"KU Eckardt","year":"2015","unstructured":"Eckardt, K. U. et al. Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management\u2013A KDIGO consensus report. Kidney Int 88, 676\u2013683, https:\/\/doi.org\/10.1038\/ki.2015.28 (2015).","journal-title":"Kidney Int"},{"key":"38713_CR13","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1172\/jci80877","volume":"125","author":"M Verbitsky","year":"2015","unstructured":"Verbitsky, M. et al. Genomic imbalances in pediatric patients with chronic kidney disease. Journal of Clinical Investigation 125, 2171\u20132178, https:\/\/doi.org\/10.1172\/jci80877 (2015).","journal-title":"Journal of Clinical Investigation"},{"issue":"11","key":"38713_CR14","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.2337\/dc16-2462","volume":"40","author":"DCE Dubois-Laforgue","year":"2017","unstructured":"Dubois-Laforgue, D. C. E., Saint-Martin, C., Coste, J., Bellann\u00e9-Chantelot, C. & Timsit, J. Diabetes, Associated Clinical Spectrum, Long-term Prognosis, and Genotype\/Phenotype Correlations in 201 Adult Patients With Hepatocyte Nuclear Factor 1B (HNF1B) Molecular Defects. Diabetes Care. Nov 40(11), 1436\u20131443 (2017).","journal-title":"Diabetes Care. Nov"},{"key":"38713_CR15","doi-asserted-by":"crossref","unstructured":"Musetti, C. Q. M. et al. Chronic renal failure of unknown origin is caused by HNF1B mutations in 9% of adult patients: a single centre cohort analysis. Nephrology (Carlton). 19(4), 202\u20139 (2014).","DOI":"10.1111\/nep.12199"},{"key":"38713_CR16","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1681\/asn.2008060633","volume":"20","author":"S Adalat","year":"2009","unstructured":"Adalat, S. et al. HNF1B Mutations Associate with Hypomagnesemia and Renal Magnesium Wasting. Journal of the American Society of Nephrology 20, 1123\u20131131, https:\/\/doi.org\/10.1681\/asn.2008060633 (2009).","journal-title":"Journal of the American Society of Nephrology"},{"key":"38713_CR17","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.2215\/cjn.06810909","volume":"5","author":"L Heidet","year":"2010","unstructured":"Heidet, L. et al. Spectrum of HNF1B Mutations in a Large Cohort of Patients Who Harbor Renal Diseases. Clinical Journal of the American Society of Nephrology 5, 1079\u20131090, https:\/\/doi.org\/10.2215\/cjn.06810909 (2010).","journal-title":"Clinical Journal of the American Society of Nephrology"},{"issue":"2","key":"38713_CR18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1681\/ASN.2015050544","volume":"27","author":"JCBA Verhave","year":"2016","unstructured":"Verhave, J. C. B. A. & Wetzels, J. F. Nijenhuis T2. Hepatocyte Nuclear Factor 1\u03b2-Associated Kidney Disease: More than Renal Cysts and Diabetes. J Am Soc Nephrol. Feb 27(2), 345\u201353 (2016).","journal-title":"J Am Soc Nephrol. Feb"},{"key":"38713_CR19","doi-asserted-by":"crossref","unstructured":"Bingham, C. et al Atypical familial juvenile hyperuricemic nephropathy associated with a hepatocyte nuclear factor-1beta gene mutation. Kidney Int. 63(5), 1645\u201351 (2003).","DOI":"10.1046\/j.1523-1755.2003.00903.x"},{"key":"38713_CR20","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1681\/asn.2006091057","volume":"18","author":"S Decramer","year":"2007","unstructured":"Decramer, S. et al. Anomalies of the TCF2 gene are the main cause of fetal bilateral hyperechogenic kidneys. Journal of the American Society of Nephrology 18, 923\u2013933, https:\/\/doi.org\/10.1681\/asn.2006091057 (2007).","journal-title":"Journal of the American Society of Nephrology"},{"key":"38713_CR21","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1136\/jmg.2005.032854","volume":"43","author":"EL Edghill","year":"2006","unstructured":"Edghill, E. L., Bingham, C., Ellard, S. & Hattersley, A. T. Mutations in hepatocyte nuclear factor-1 beta and their related phenotypes. Journal of Medical Genetics 43, 84\u201390, https:\/\/doi.org\/10.1136\/jmg.2005.032854 (2006).","journal-title":"Journal of Medical Genetics"},{"key":"38713_CR22","doi-asserted-by":"publisher","first-page":"E356","DOI":"10.1542\/peds.2010-3467","volume":"129","author":"J Drube","year":"2012","unstructured":"Drube, J. et al. Urinary Proteome Analysis to Exclude Severe Vesicoureteral Reflux. Pediatrics 129, E356\u2013E363, https:\/\/doi.org\/10.1542\/peds.2010-3467 (2012).","journal-title":"Pediatrics"},{"key":"38713_CR23","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1074\/mcp.M110.001917","volume":"9","author":"DM Good","year":"2010","unstructured":"Good, D. M. et al. Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease. Molecular & Cellular Proteomics 9, 2424\u20132437, https:\/\/doi.org\/10.1074\/mcp.M110.001917 (2010).","journal-title":"Molecular & Cellular Proteomics"},{"key":"38713_CR24","doi-asserted-by":"publisher","unstructured":"Kistler, A. D. et al. Urinary Proteomic Biomarkers for Diagnosis and Risk Stratification of Autosomal Dominant Polycystic Kidney Disease: A Multicentric Study. Plos One 8, https:\/\/doi.org\/10.1371\/journal.pone.0053016 (2013).","DOI":"10.1371\/journal.pone.0053016"},{"key":"38713_CR25","doi-asserted-by":"publisher","unstructured":"Klein, J. et al. Fetal Urinary Peptides to Predict Postnatal Outcome of Renal Disease in Fetuses with Posterior Urethral Valves (PUV). Science Translational Medicine 5, https:\/\/doi.org\/10.1126\/scitranslmed.3005807 (2013).","DOI":"10.1126\/scitranslmed.3005807"},{"key":"38713_CR26","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/prca.200800024","volume":"2","author":"JJ Coon","year":"2008","unstructured":"Coon, J. J. et al. CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics. Proteomics Clinical Applications 2, 964\u2013973, https:\/\/doi.org\/10.1002\/prca.200800024 (2008).","journal-title":"Proteomics Clinical Applications"},{"key":"38713_CR27","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/prca.201000155","volume":"5","author":"J Siwy","year":"2011","unstructured":"Siwy, J., Mullen, W., Golovko, I., Franke, J. & Zuerbig, P. Human urinary peptide database for multiple disease biomarker discovery. Proteomics Clinical Applications 5, 367\u2013374, https:\/\/doi.org\/10.1002\/prca.201000155 (2011).","journal-title":"Proteomics Clinical Applications"},{"key":"38713_CR28","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1002\/elps.201200708","volume":"34","author":"A Stalmach","year":"2013","unstructured":"Stalmach, A., Albalat, A., Mullen, W. & Mischak, H. Recent advances in capillary electrophoresis coupled to mass spectrometry for clinical proteomic applications. Electrophoresis 34, 1452\u20131464, https:\/\/doi.org\/10.1002\/elps.201200708 (2013).","journal-title":"Electrophoresis"},{"key":"38713_CR29","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the False Discovery Rate - A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B-Methodological 57, 289\u2013300 (1995).","journal-title":"Journal of the Royal Statistical Society Series B-Methodological"},{"key":"38713_CR30","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/prca.200600771","volume":"1","author":"H Mischak","year":"2007","unstructured":"Mischak, H. et al. Clinical proteomics: A need to define the field and to begin to set adequate standards. Proteomics Clinical Applications 1, 148\u2013156, https:\/\/doi.org\/10.1002\/prca.200600771 (2007).","journal-title":"Proteomics Clinical Applications"},{"key":"38713_CR31","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.bbaexp.2005.10.003","volume":"1731","author":"S Senkel","year":"2005","unstructured":"Senkel, S., Lucas, B., Klein-Hitpass, L. & Ryffel, G. U. Identification of target genes of the transcription factor HNF1 beta and HNF1 alpha in a human embryonic kidney cell line. Biochimica Et Biophysica Acta-Gene Structure and Expression 1731, 179\u2013190, https:\/\/doi.org\/10.1016\/j.bbaexp.2005.10.003 (2005).","journal-title":"Biochimica Et Biophysica Acta-Gene Structure and Expression"},{"key":"38713_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/ki.2009.93","volume":"76","author":"AD Kistler","year":"2009","unstructured":"Kistler, A. D. et al. Identification of a unique urinary biomarker profile in patients with autosomal dominant polycystic kidney disease. Kidney International 76, 89\u201396, https:\/\/doi.org\/10.1038\/ki.2009.93 (2009).","journal-title":"Kidney International"},{"key":"38713_CR33","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.bbadis.2011.06.012","volume":"1812","author":"J Norman","year":"2011","unstructured":"Norman, J. Fibrosis and progression of Autosomal Dominant Polycystic Kidney Disease (ADPKD). Biochimica Et Biophysica Acta-Molecular Basis of Disease 1812, 1327\u20131336, https:\/\/doi.org\/10.1016\/j.bbadis.2011.06.012 (2011).","journal-title":"Biochimica Et Biophysica Acta-Molecular Basis of Disease"},{"key":"38713_CR34","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1093\/ndt\/gfp063","volume":"24","author":"J Drube","year":"2009","unstructured":"Drube, J. et al. Urinary proteome pattern in children with renal Fanconi syndrome. Nephrology Dialysis Transplantation 24, 2161\u20132169, https:\/\/doi.org\/10.1093\/ndt\/gfp063 (2009).","journal-title":"Nephrology Dialysis Transplantation"},{"key":"38713_CR35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1755-1536-7-4","volume":"7","author":"F Genovese","year":"2014","unstructured":"Genovese, F., Manresa, A. A., Leeming, D. J., Karsdal, M. A. & Boor, P. The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis? Fibrogenesis Tissue Repair 7, 4, https:\/\/doi.org\/10.1186\/1755-1536-7-4 (2014).","journal-title":"Fibrogenesis Tissue Repair"},{"key":"38713_CR36","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/prca.200780166","volume":"2","author":"K Rossing","year":"2008","unstructured":"Rossing, K. et al. The urinary proteome in diabetes and diabetes-associated complications: New ways to assess disease progression and evaluate therapy. Proteomics Clin Appl 2, 997\u20131007, https:\/\/doi.org\/10.1002\/prca.200780166 (2008).","journal-title":"Proteomics Clin Appl"},{"key":"38713_CR37","doi-asserted-by":"crossref","unstructured":"Magalh\u00e3es, P. et al. Association of kidney fibrosis with urinary peptides: a path towards non-invasive liquid biopsies? Sci Rep. 20 5, 7(1), 16915 (2017).","DOI":"10.1038\/s41598-017-17083-w"},{"key":"38713_CR38","doi-asserted-by":"publisher","unstructured":"Ovrehus, M. A., Zurbig, P., Vikse, B. E. & Hallan, S. I. Urinary proteomics in chronic kidney disease: diagnosis and risk of progression beyond albuminuria. Clinical Proteomics 12, https:\/\/doi.org\/10.1186\/s12014-015-9092-7 (2015).","DOI":"10.1186\/s12014-015-9092-7"},{"key":"38713_CR39","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1053\/j.ajkd.2011.10.054","volume":"59","author":"TM El-Achkar","year":"2012","unstructured":"El-Achkar, T. M. & Wu, X. R. Uromodulin in Kidney Injury: An Instigator, Bystander, or Protector? American Journal of Kidney Diseases 59, 452\u2013461, https:\/\/doi.org\/10.1053\/j.ajkd.2011.10.054 (2012).","journal-title":"American Journal of Kidney Diseases"},{"key":"38713_CR40","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.ekir.2017.03.012","volume":"2","author":"ZY Zhang","year":"2017","unstructured":"Zhang, Z. Y. et al. A Urinary Fragment of Mucin-1 Subunit alpha Is a Novel Biomarker Associated With Renal Dysfunction in the General Population. Kidney Int Rep 2, 811\u2013820, https:\/\/doi.org\/10.1016\/j.ekir.2017.03.012 (2017).","journal-title":"Kidney Int Rep"},{"key":"38713_CR41","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1046\/j.1523-1755.2001.00032.x","volume":"60","author":"YS Xie","year":"2001","unstructured":"Xie, Y. S. et al. Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney International 60, 1645\u20131657, https:\/\/doi.org\/10.1046\/j.1523-1755.2001.00032.x (2001).","journal-title":"Kidney International"},{"issue":"10","key":"38713_CR42","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1681\/ASN.2018040437","volume":"29","author":"SC Chan","year":"2018","unstructured":"Chan, S. C. et al. Mechanism of Fibrosis in HNF1B-Related Autosomal Dominant Tubulointerstitial Kidney Disease. J Am Soc Nephrol. Oct 29(10), 2493\u20132509 (2018).","journal-title":"J Am Soc Nephrol. Oct"},{"key":"38713_CR43","doi-asserted-by":"publisher","first-page":"F27","DOI":"10.1152\/ajprenal.00601.2017","volume":"315","author":"A Kompatscher","year":"2018","unstructured":"Kompatscher, A. et al. Transcription factor HNF1beta regulates expression of the calcium-sensing receptor in the thick ascending limb of the kidney. Am J Physiol Renal Physiol 315, F27\u2013F35, https:\/\/doi.org\/10.1152\/ajprenal.00601.2017 (2018).","journal-title":"Am J Physiol Renal Physiol"},{"key":"38713_CR44","doi-asserted-by":"publisher","first-page":"14283","DOI":"10.1073\/pnas.1412323111","volume":"111","author":"IY Kuo","year":"2014","unstructured":"Kuo, I. Y. et al. Cyst formation following disruption of intracellular calcium signaling. Proceedings of the National Academy of Sciences of the United States of America 111, 14283\u201314288, https:\/\/doi.org\/10.1073\/pnas.1412323111 (2014).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"38713_CR45","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.bbadis.2010.09.016","volume":"1812","author":"S Abdul-Majeed","year":"2011","unstructured":"Abdul-Majeed, S. & Nauli, S. M. Calcium-mediated mechanisms of cystic expansion. Biochimica Et Biophysica Acta-Molecular Basis of Disease 1812, 1281\u20131290, https:\/\/doi.org\/10.1016\/j.bbadis.2010.09.016 (2011).","journal-title":"Biochimica Et Biophysica Acta-Molecular Basis of Disease"},{"key":"38713_CR46","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1101\/gad.173443.111","volume":"25","author":"KJ Wright","year":"2011","unstructured":"Wright, K. J. et al. An ARL3-UNC119-RP2 GTPase cycle targets myristoylated NPHP3 to the primary cilium. Genes Dev 25, 2347\u20132360, https:\/\/doi.org\/10.1101\/gad.173443.111 (2011).","journal-title":"Genes Dev"},{"key":"38713_CR47","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1038\/sj.emboj.7600160","volume":"23","author":"L Gresh","year":"2004","unstructured":"Gresh, L. et al. A transcriptional network in polycystic kidney disease. Embo Journal 23, 1657\u20131668, https:\/\/doi.org\/10.1038\/sj.emboj.7600160 (2004).","journal-title":"Embo Journal"},{"key":"38713_CR48","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00467-013-2706-2","volume":"30","author":"C Bergmann","year":"2015","unstructured":"Bergmann, C. ARPKD and early manifestations of ADPKD: the original polycystic kidney disease and phenocopies. Pediatric Nephrology 30, 15\u201330, https:\/\/doi.org\/10.1007\/s00467-013-2706-2 (2015).","journal-title":"Pediatric Nephrology"},{"key":"38713_CR49","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/ki.2014.202","volume":"86","author":"S Faguer","year":"2014","unstructured":"Faguer, S. et al. The HNF1B score is a simple tool to select patients for HNF1B gene analysis. Kidney International 86, 1007\u20131015, https:\/\/doi.org\/10.1038\/ki.2014.202 (2014).","journal-title":"Kidney International"},{"key":"38713_CR50","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1093\/hmg\/dds141","volume":"21","author":"M Paces-Fessy","year":"2012","unstructured":"Paces-Fessy, M., Fabre, M., Lesaulnier, C. & Cereghini, S. Hnf1b and Pax2 cooperate to control different pathways in kidney and ureter morphogenesis. Human Molecular Genetics 21, 3143\u20133155, https:\/\/doi.org\/10.1093\/hmg\/dds141 (2012).","journal-title":"Human Molecular Genetics"},{"key":"38713_CR51","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1053\/j.ackd.2011.05.001","volume":"18","author":"KM Dell","year":"2011","unstructured":"Dell, K. M. The Spectrum of Polycystic Kidney Disease in Children. Advances in Chronic Kidney Disease 18, 339\u2013347, https:\/\/doi.org\/10.1053\/j.ackd.2011.05.001 (2011).","journal-title":"Advances in Chronic Kidney Disease"},{"key":"38713_CR52","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/ndt\/gfw243","volume":"32","author":"M Pejchinovski","year":"2017","unstructured":"Pejchinovski, M. et al. Urine peptidome analysis predicts risk of end-stage renal disease and reveals proteolytic pathways involved in autosomal dominant polycystic kidney disease progression. Nephrology Dialysis Transplantation 32, 487\u2013497, https:\/\/doi.org\/10.1093\/ndt\/gfw243 (2017).","journal-title":"Nephrology Dialysis Transplantation"},{"key":"38713_CR53","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1093\/ndt\/gfw337","volume":"32","author":"J Siwy","year":"2017","unstructured":"Siwy, J. et al. Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis. Nephrology Dialysis Transplantation 32, 2079\u20132089, https:\/\/doi.org\/10.1093\/ndt\/gfw337 (2017).","journal-title":"Nephrology Dialysis Transplantation"},{"key":"38713_CR54","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1074\/mcp.M800529-MCP200","volume":"8","author":"M Haubitz","year":"2009","unstructured":"Haubitz, M. et al. Identification and Validation of Urinary Biomarkers for Differential Diagnosis and Evaluation of Therapeutic Intervention in Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis. Molecular & Cellular Proteomics 8, 2296\u20132307, https:\/\/doi.org\/10.1074\/mcp.M800529-MCP200 (2009).","journal-title":"Molecular & Cellular Proteomics"},{"key":"38713_CR55","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/nm1384","volume":"12","author":"S Decramer","year":"2006","unstructured":"Decramer, S. et al. Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nature Medicine 12, 398\u2013400, https:\/\/doi.org\/10.1038\/nm1384 (2006).","journal-title":"Nature Medicine"},{"key":"38713_CR56","doi-asserted-by":"publisher","first-page":"4469","DOI":"10.1002\/elps.200700237","volume":"28","author":"BA Julian","year":"2007","unstructured":"Julian, B. A. et al. Electrophoretic methods for analysis of urinary polypeptides in IgA-associated renal diseases. Electrophoresis 28, 4469\u20134483, https:\/\/doi.org\/10.1002\/elps.200700237 (2007).","journal-title":"Electrophoresis"},{"key":"38713_CR57","doi-asserted-by":"publisher","first-page":"592","DOI":"10.2215\/cjn.06260614","volume":"10","author":"A Trautmann","year":"2015","unstructured":"Trautmann, A. et al. Spectrum of Steroid-Resistant and Congenital Nephrotic Syndrome in Children: The PodoNet Registry Cohort. Clinical Journal of the American Society of Nephrology 10, 592\u2013600, https:\/\/doi.org\/10.2215\/cjn.06260614 (2015).","journal-title":"Clinical Journal of the American Society of Nephrology"},{"key":"38713_CR58","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/prca.200900189","volume":"4","author":"H Mischak","year":"2010","unstructured":"Mischak, H. et al. Comprehensive human urine standards for comparability and standardization in clinical proteome analysis. Proteomics Clinical Applications 4, 464\u2013478, https:\/\/doi.org\/10.1002\/prca.200900189 (2010).","journal-title":"Proteomics Clinical Applications"},{"key":"38713_CR59","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz, G. J. et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20, 629\u2013637, https:\/\/doi.org\/10.1681\/ASN.2008030287 (2009).","journal-title":"J Am Soc Nephrol"},{"key":"38713_CR60","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey, A. S. et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 150, 604\u2013612 (2009).","journal-title":"Ann Intern Med"},{"key":"38713_CR61","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1136\/gutjnl-2012-302047","volume":"62","author":"J Metzger","year":"2013","unstructured":"Metzger, J. et al. Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders. Gut 62, 122\u2013130, https:\/\/doi.org\/10.1136\/gutjnl-2012-302047 (2013).","journal-title":"Gut"},{"key":"38713_CR62","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.clinbiochem.2012.09.025","volume":"46","author":"H Mischak","year":"2013","unstructured":"Mischak, H., Vlahou, A. & Ioannidis, J. P. A. Technical aspects and inter-laboratory variability in native peptide profiling: The CE-MS experience. Clinical Biochemistry 46, 432\u2013443, https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.09.025 (2013).","journal-title":"Clinical Biochemistry"},{"key":"38713_CR63","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0021-9673(03)00712-X","volume":"1013","author":"THA Kaiser","year":"2003","unstructured":"Kaiser, T. H. A. & Kielstein, J. T. Conference: 16th International Symposium on Microscale Separation and Analysis Location: SAN DIEGO, CALIFORNIA. Journal of Chromatography 1013, 157\u2013171 (2003).","journal-title":"Journal of Chromatography"},{"key":"38713_CR64","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1021\/pr800401m","volume":"8","author":"J Jantos-Siwy","year":"2009","unstructured":"Jantos-Siwy, J. et al. Quantitative Urinary Proteome Analysis for Biomarker Evaluation in Chronic Kidney Disease. Journal of Proteome Research 8, 268\u2013281, https:\/\/doi.org\/10.1021\/pr800401m (2009).","journal-title":"Journal of Proteome Research"},{"key":"38713_CR65","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/elps.201300327","volume":"35","author":"J Klein","year":"2014","unstructured":"Klein, J., Papadopoulos, T., Mischak, H. & Mullen, W. Comparison of CE-MS\/MS and LC-MS\/MS sequencing demonstrates significant complementarity in natural peptide identification in human urine. Electrophoresis 35, 1060\u20131064, https:\/\/doi.org\/10.1002\/elps.201300327 (2014).","journal-title":"Electrophoresis"},{"key":"38713_CR66","doi-asserted-by":"publisher","unstructured":"Magalh\u00e3es, P. et al. Comparison of Urine and Plasma Peptidome Indicates Selectivity in Renal Peptide Handling. Proteomics. Clinical applications, e1700163-e1700163, https:\/\/doi.org\/10.1002\/prca.201700163 (2018).","DOI":"10.1002\/prca.201700163"},{"key":"38713_CR67","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1002\/elps.200500827","volume":"27","author":"P Zurbig","year":"2006","unstructured":"Zurbig, P. et al. Biomarker discovery by CE-MS enables sequence analysis via MS\/MS with platform-independent separation. Electrophoresis 27, 2111\u20132125, https:\/\/doi.org\/10.1002\/elps.200500827 (2006).","journal-title":"Electrophoresis"},{"issue":"1","key":"38713_CR68","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ddtec.2006.03.010","volume":"3","author":"MMH Girolami","year":"2006","unstructured":"Girolami, M. M. H. & Krebs, R. Analysis of complex, multidimensional datasets. Drug Discov Today Technol. Spring 3(1), 13\u20139 (2006).","journal-title":"Drug Discov Today Technol. Spring"},{"key":"38713_CR69","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/bioinformatics\/btg477","volume":"20","author":"ZR Yang","year":"2004","unstructured":"Yang, Z. R. & Chou, K. C. Bio-support vector machines for computational proteomics. Bioinformatics 20, 735\u2013U549, https:\/\/doi.org\/10.1093\/bioinformatics\/btg477 (2004).","journal-title":"Bioinformatics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-38713-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-38713-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-38713-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T06:08:20Z","timestamp":1671257300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-38713-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,18]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["38713"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-38713-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,18]]},"assertion":[{"value":"30 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.M. is the founder and co-owner of Mosaiques Diagnostic GmbH, who developed the CE-MS technology for clinical application. P.M., M.K., M.P., I.B., and P.Z. are employees of Mosaiques Diagnostic GmbH.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"2225"}}